Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease
- 31 October 2010
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 40 (1), 120-129
- https://doi.org/10.1016/j.nbd.2010.03.019
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicityJournal of Neurochemistry, 2009
- Antipsychotic‐induced movement disorders – forgotten but not goneActa Psychiatrica Scandinavica, 2008
- Oxidative Stress and NeurotoxicityChemical Research in Toxicology, 2007
- Caenorhabditis elegans as a Model System for Parkinson’s DiseaseNeurodegenerative Diseases, 2007
- Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicityNeurobiology of Disease, 2005
- Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10Journal of Neurochemistry, 2005
- Antioxidants as treatment for neurodegenerative disordersExpert Opinion on Investigational Drugs, 2002
- Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal lossJournal of Neurochemistry, 2001
- A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatumLife Sciences, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983